{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:41:00Z","timestamp":1772142060849,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ijrobp.2009.04.015","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T08:25:47Z","timestamp":1250670347000},"page":"164-169","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Concurrent Topotecan and Radiation on 6-Month Progression-Free Survival in the Primary Treatment of Glioblastoma Multiforme"],"prefix":"10.1016","volume":"75","author":[{"given":"Gerhard G.","family":"Grabenbauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Dieter","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Ganslandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunther","family":"Klautke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Birkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2009.04.015_bib1","first-page":"80","article-title":"DNA topoisomerase I inhibitors","volume":"17","author":"Takimoto","year":"1997","journal-title":"Cancer Chemother Biol Response Modif"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00686188","article-title":"Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors","volume":"36","author":"Houghton","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1200\/JCO.2004.07.110","article-title":"Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors","volume":"22","author":"Daw","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib4","first-page":"633","article-title":"A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumors","volume":"9","author":"Santana","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib5","first-page":"1153","article-title":"Oral topotecan given once or twice daily for ten days: A phase I pharmacology study in adult patients with solid tumors","volume":"4","author":"Gerrits","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib6","first-page":"3327","article-title":"In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude mice","volume":"6","author":"Chastagner","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0360-3016(01)01501-2","article-title":"Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice","volume":"50","author":"Chastagner","year":"2001","journal-title":"In J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-005-3666-6","article-title":"Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts","volume":"76","author":"Pinel","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0360-3016(02)02817-1","article-title":"Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group 9513","volume":"53","author":"Fisher","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1021100413142","article-title":"Prolonged infusional topotecan and accelerated hyperfractionated 3d-conformal radiation in patients with newly diagnosed glioblastoma\u2014a phase I study","volume":"60","author":"Grabenbauer","year":"2002","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-005-9028-6","article-title":"Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme","volume":"77","author":"Klautke","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clineuro.2004.07.016","article-title":"Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults","volume":"107","author":"Gross","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib13","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/cncr.21534","article-title":"Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: Results of a French Society of Paediatric Oncology Phase II Study","volume":"104","author":"Bernier-Chastagner","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"MacDonald","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1215\/15228517-2006-001","article-title":"Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model","volume":"8","author":"Saito","year":"2006","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1215\/15228517-2006-016","article-title":"Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicine) in intracranial brain tumor xenografts","volume":"9","author":"Yamashita","year":"2007","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/14737140.8.5.707","article-title":"Topoisomerase I inhibitors for the treatment of brain tumors","volume":"8","author":"Feun","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/02841860510007611","article-title":"Modified optimal fractionation for poor prognosis malignant gliomas: An elusive search","volume":"44","author":"Gupta","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0360-3016(00)01458-9","article-title":"Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) vs. standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme","volume":"49","author":"Prados","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijrobp.2008.04.030","article-title":"Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis","volume":"73","author":"Panet-Raymond","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.015_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijrobp.2008.05.034","article-title":"Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: RTOG Trial 98-03","volume":"73","author":"Tsien","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609005811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609005811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T02:22:50Z","timestamp":1558491770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609005811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0360301609005811"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.015","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}